1. Late-breaking trials at the ACC scientific sessions: Insights and controversy

   • Steven E. Nissen

   Editor’s Commentary 16 October 2008 Pages: 247 - 249

2. Web alert

   OriginalPaper 16 October 2008 Pages: 250 - 250

3. Late adverse events after drug-eluting stent implantation

   • David F. Kong
   • Eric L. Eisenstein
   • Robert A. Harrington

   OriginalPaper 16 October 2008 Pages: 253 - 262

4. The evolving role of medical therapy for chronic stable angina

   • Freidy Eid
   • William E. Boden

   OriginalPaper 16 October 2008 Pages: 263 - 271

5. Optimal treatment of the diabetic patient with multivessel disease

   • Sameer Bansilal
   • Michael E. Farkouh
   • Valentin Fuster

   OriginalPaper 16 October 2008 Pages: 272 - 284

6. Lessons learned from the CRUSADE National Quality Improvement Initiative

   • Eric D. Peterson
   • David Z. Bynum
   • Matthew T. Roe

   OriginalPaper 16 October 2008 Pages: 285 - 290

7. New data on early management of patients with ST-elevation myocardial infarction

   • David P. Faxon

   OriginalPaper 16 October 2008 Pages: 291 - 298

8. Should prasugrel or clopidogrel be used in patients with ACS?

   • Neal S. Kleiman

   Clinical Trials Report 16 October 2008 Pages: 301 - 302

9. Early intervention: Which patients and how early?

   • J. Matthew Brennan
   • John L. Petersen

   OriginalPaper 16 October 2008 Pages: 303 - 311

10. Which heparin and how much?

    • Peter E. Ruchin
    • Marino Labinaz

    OriginalPaper 16 October 2008 Pages: 312 - 318

11. Sorting through new biomarkers

    • Frances O. Wood
    • James A. de Lemos

    OriginalPaper 16 October 2008 Pages: 319 - 326

12. Antiplatelet therapy in acute coronary syndromes

    • Colin M. Barker
    • Matthew J. Price

    OriginalPaper 16 October 2008 Pages: 327 - 333

13. Lipid management: Considerations in acute coronary syndrome

    • Venkateshwar R. Polsani
    • Salim S. Virani
    • Vijay Nambi

    OriginalPaper 16 October 2008 Pages: 334 - 341